SCHEMBL369755

SCHEMBL369755

Cc1ccnc(Nc2nc(-c3c[nH]nc3-c3cncc(Cl)c3)cs2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 3/20 0.42
GRM8 O00222 1/20 0.42
MEN1 O00255 11/20 0.40
KMT2A Q03164 11/20 0.40
RAB9A P51151 8/20 0.40
NPC1 O15118 7/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
ATM Q13315 1/20 0.40
SMN1; SMN2 Q16637 4/20 0.38
MAPT P10636 4/20 0.38
PKM P14618 1/20 0.38
POLB P06746 2/20 0.37
CYP1A2 P05177 1/20 0.37
THRB P10828 1/20 0.37
ALDH1A1 P00352 2/20 0.36
KDM1A O60341 1/20 0.36
MAOA P21397 1/20 0.36
TYR P14679 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15166594 0.88 NPC1 (0.46) GRM4GRM8MEN1KMT2ARAB9A
SCHEMBL370966 0.86 GRM4 (0.45) GRM4GRM8MEN1KMT2ARAB9A
SCHEMBL369639 0.86 GRM4 (0.39) GRM4GRM8MEN1KMT2ARAB9A
SCHEMBL370036 0.84 RAB9A (0.52) GRM4GRM8MEN1KMT2ARAB9A
SCHEMBL15166813 0.83 MEN1 (0.50) GRM4GRM8MEN1KMT2ARAB9A
SCHEMBL368784 0.83 NPC1 (0.44) GRM4GRM8MEN1KMT2ARAB9A
SCHEMBL12482779 0.81 NPC1 (0.44) GRM4GRM8MEN1KMT2ARAB9A
SCHEMBL369982 0.81 KMT2A (0.49) GRM4GRM8MEN1KMT2ARAB9A
SCHEMBL370584 0.80 NPC1 (0.40) GRM4GRM8MEN1KMT2ARAB9A
SCHEMBL12482631 0.79 VCP (0.43) GRM4GRM8MEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130210809-A1 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS BOLEA CHRISTELLE (CH) 2013-08-15 US claimed
EP-2595986-A2 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS Addex Pharma SA (CH) 2013-05-29 EP claimed
WO-2012009009-A2 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMA S.A. (CH) 2012-01-19 WO claimed
US-20130210809-A1 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS BOLEA CHRISTELLE (CH) 2013-08-15 US disclosed
EP-2595986-A2 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS Addex Pharma SA (CH) 2013-05-29 EP disclosed
WO-2012009009-A2 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMA S.A. (CH) 2012-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130210809-A1 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS GRM2, GRM4, GRM1 GRM4 2/4885GRM8 23/4885MEN1 4364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.